Risk factor
Very poor trading liquidity
Profitability factor
Greatly overvalued vs peers
About
Aspira Pathlab & Diagnostics Ltd. specializes in managing diagnostic centers and laboratories. The company performs an extensive range of pathological analyses, encompassing biochemistry, hematology, histopathology, microbiology, immunochemistry, immunology, virology, cytology, in addition to other pathological and radiological examinations. Their services also include corporate health solutions like on-site and remote employee health assessments, quick industry-specific screenings conducted at client locations, secure and private handling of employee data, and personalized packages tailored to specific industry requirements. Founded on July 3, 1973, the firm is headquartered in Navi Mumbai, India.
Company Valuation
Based on key historical and expected multiples, the stock is greatly overvalued relative to its peers. In particular, the stock is overpriced on P/E, 'expensive' on EV/EB